Download PDF Welcome back from the winter break and happy 2021! According to JPMorgan, the outlook of M&A in 2021 is very positive. Indeed, mainly due to a reduction in political uncertainty, the development of vaccines and strong capital markets, there is increased confidence in management and board of directors, Read more…
Download PDF Introduction The pharmaceuticals sector has been the center of attention lately for the successful vaccines trial that finally gave some hope of recovery, even though it wasn’t without controversies. However, a lot more has been going on in the industry that might change the reputation that the industry Read more…
Download PDF Introduction After stalling in winter and spring 2020 due to the coronavirus, M&A activity picked up over the summer, fuelled by a bullish stock market. The situation remains dire however: according to MergerMarket data, companies have struck €620bn worth of M&A deals in the three months Read more…
Download as PDF BSIC has brought you some of the most interesting deals over the last week, we hope you’ll enjoy! Elliot Management builds a 4% stake in Twitter Deal Value: $1bn | Deal Type: Shareholder Activism | Date: 01-Mar-2020 | Nationality: US | Sector: Technology Paul Singer has succeeded in building a stake in Twitter worth more Read more…
In this article, we will analyze the upcoming Democratic Party Primaries for the 2020 US Presidential elections from a markets point of view. We will start by introducing the Democratic Party primary system for electing the Democratic Party’s Nominee who will face President Trump on the 2020 elections, after introducing Read more…
Alphabet Inc. [GOOGL:NASDAQ] – Market Cap as of 09/11/2019 $903.46bn Fitbit Inc. [FIT:NYSE] – Market Cap as of 09/11/2019 $1.83bn Introduction On the 28th of October 2019 initial reports suggested the interest of the tech giant Alphabet, the parent company behind Google, in acquiring Fitbit, a wearable device company. Finally, Read more…
Boston Scientific Corporation (NYSE: BTX) – market cap as of 27/11/2018: USD 48.57bn Introduction On November 20, 2018, Boston Scientific, a company operating as a provider of innovative medical solutions, successfully reached an agreement to acquire BTG plc, the UK developer and distributor of tools employed in the treatment of Read more…
Athenahealth (NASDAQ: ATHN) – market cap as of 11/22/2018: $5.36bn Introduction On the 12th of November 2018, private equity firm Veritas Capital and hedge fund Elliot Management announced their plan to buy Athenahealth Inc. for $5.7bn in an all-cash deal. The deal values Athenahealth at $135 per share, thus offering Read more…
Novartis AG (SIX: NOVN) – market cap as of 20/04/2018: CHF204.12bn AveXis Inc (NASDAQ: AVXS) – market cap as of 20/04/2018: $7.62bn Introduction On April 9, Novartis submitted an offer to acquire all the shares of the American gene therapy group AveXis. The Swiss drugmaker offered an 88% premium adding Read more…
Siemens AG (ETR: SIE) – market cap as of 06/04/2018: €88.8bn Siemens Healthineers AG (ETR: SHL) – market cap as of 06/04/2018: €33.9bn Introduction On March 16, 2018, the German conglomerate Siemens performed an initial public offering of its principal and second most profitable division, Healthineers, on the Frankfurt Stock Read more…
CIGNA Corporation (NYSE:CI) – market cap as of 09/03/2018: $42.7bn Express Scripts Holding Co (NASDAQ:ESRX) – market cap as of 09/03/2018: $45.7bn Introduction On March 8, 2018, Cigna Corporation announced the acquisition of Express Scripts Holding for a cash and stock consideration of $67bn. The combination of Cigna – a Read more…
Rite Aid (NYSE:RAD) – market cap as of 23/02/2018: $2.22bn Introduction On the 20th February, Rite Aid Corporation, one of the leading US drugstore chains, entered into a definitive merger agreement with Albertsons Companies, one of the largest American private equity-backed grocery retailers. The deal will result in the creation of a Read more…
Novartis AG (NYSE:NVS) – market cap as of 04/11/2017: $219bn Advanced Accelerator Applications SA (NASDAQ:AAAP) – market cap as of 04/11/2017: $3.56bn Introduction On October 30, 2017, Novartis announced its intention to make a tender offer for 100% of the share capital of Advanced Accelerator Applications, for a total consideration Read more…
Impax Laboratories, Inc. (IPXL:NASDAQ) – market cap as of 27/10/2017: $1.40bn Introduction On October 17, 2017, Amneal Pharmaceuticals and Impax Laboratories announced that they will merge in an all-stock transaction. Amneal will hold c. 75% of the combined entity, whereas Impax shareholders will own the remaining stake (c. 25%). These Read more…
Kite Pharma (NASDAQ:KITE) – Market cap as of 23/09/2017: $10.28bn Gilead Sciences (NASDAQ:GILD) – Market cap as of 23/09/2017: $108.74bn Introduction On August 28, 2017, Gilead Sciences, Inc. and Kite Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Kite for Read more…